SkyePharma Income Statement
View: Annual
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 83.0 | 84.2 | 105.5 |
| Cost of Goods Sold | -- | -- | 50.3 |
| Gross Profit | -- | -- | 55.2 |
| Gross Profit Margin | 0.0% | 0.0% | 52.4% |
| SG&A Expense | -- | -- | 119.4 |
| Depreciation & Amortization | -- | -- | -- |
| Operating Income | -- | -- | (64.2) |
| Operating Margin | -- | -- | -- |
| Nonoperating Income | -- | -- | 18.1 |
| Nonoperating Expenses | -- | -- | 38.4 |
| Income Before Taxes | -- | -- | (84.5) |
| Income Taxes | -- | -- | 0.2 |
| Net Income After Taxes | 0.0 | 0.0 | (84.7) |
| Continuing Operations | -- | -- | (84.7) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | -- | -- | (84.7) |
| Total Net Income | -- | -- | (84.7) |
| Net Profit Margin | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | -- | -- | (7.90) |
| Dividends per Share | -- | -- | -- |





